Skip to content

Evaluation of Dental Implant Placement in the Sloped Alveolar Ridge

Evaluation of Dental Implant Placement in the Sloped Alveolar Ridge

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03543618
Enrollment
40
Registered
2018-06-01
Start date
2018-03-15
Completion date
2021-07-31
Last updated
2018-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophy of Edentulous Alveolar Ridge

Keywords

dental implant, edentulous ridge

Brief summary

The aim of this study was to investigate the therapeutic effect of sloped dental implants. It can reduce the need of osteoectomy, reduce discomfort of procedures, and is easier for maintenance.

Detailed description

20 OsseoSpeed ™ Profile EV and 20 OsseoSpeed ™ EV groups will be randomly implanted into the oblique edentulous ridges of subjects, and the treatment response will be monitored for 3 years. The implantation area will be randomly divided into two groups, One group was treated with OsseoSpeed ™ Profile EV (sloped group) and the other group was treated with OsseoSpeed ™ EV (control group). The same patient had the same implant as the same quadrant. The patient will be followed up regularly for follow-up, followed by clinical attachment level, probing depth, bleeding on probing, keratinized gingival width (Keratinized gingiva), mobility (mobility) and other clinical indicators of the measurement, regular dental radiography, gingival crevicular fluid (GCF) collection and bone integration measurement. After six months of implantation, prosthesis will delivered and loaded functionally, and regular follow-up will be arranged. In each time of follow-up, examination will be carried out with regards to periodontal pocket depth, clinical attachment height, periodontal bleeding index, keratinized gingival width, and other clinical indicators of the measurement, at the end of the experiment, that is, after three years, and then a dental root film irradiation, GCF collection and osseointegration measurement.

Interventions

DEVICESloped

Placement of implant with sloped design

DEVICEControl

Placement of implant with conventional design

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

20-80 years old with appropriate oral cleaning ability; the computer tomography shows \> 1 mm buccolingual discrepancy of alveolar ridge height; no generalized periodontitis, or had history of periodontitis but has been completed treatment; no major systemic infection or major systemic illness; not taken antibiotics in the past two weeks Not pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Clinical assessment of the status of osseointegrationup to 3 yearsradiographic bone level, bone consolidation index (ISQ)

Secondary

MeasureTime frameDescription
The health status of adjacent teeth0 day, 6 months, 1 year, 2 years, 3 yearsradiographic bone level, clinical attachment level, pocket depth, periodontal bleeding (bleeding on probing), keratinized gingival width (masticatory mucosa width)
The peri-implant health1 year, 2 years, 3 yearsradiographic bone level, clinical attachment level, pocket depth, periodontal bleeding (bleeding on probing), keratinized gingival width (masticatory mucosa width)
Biomarkers in the gingival crevicular fluid of adjacent teeth0 day, 6 months, 1 year, 2 years, 3 yearsInflammatory markers such as Interleukin-1 beta, matrix metalloproteinase-8, Interleukin-8, or Interleukin-10
Biomarkers in the gingival crevicular fluid of dental implant1 year, 2 years, 3 yearsInflammatory markers such as Interleukin-1 beta, matrix metalloproteinase-8, Interleukin-8, or Interleukin-10

Countries

Taiwan

Contacts

Primary ContactPo-Chun Chang
changpc@ntu.edu.tw02-23123456
Backup ContactOlivia Hsieh
ling202643@gmail.com02-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026